Myriam Ley Martos

Myriam Ley Martos

Auto-generated profile, based on publicly available information

Myriam Ley Martos

Pediatric Neurology Unit Hospital Universitario Puerta del Mar Cádiz Spain

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 September 2023 in Journal of Inherited Metabolic Disease
Verified
Journal Article
Open access
FCFrancisco del Caño-Ochoa
Francisco del Caño-Ochoa
BNBobby G. Ng
Bobby G. Ng
ARAntonio Rubio‐Del‐Campo
Antonio Rubio‐Del‐Campo
SMSonal Mahajan
Sonal Mahajan
MWMatthew Wilson
Matthew Wilson
SRSantiago Ramon-Maiques
Santiago Ramon-Maiques
CAD is a large, 2225 amino acid multienzymatic protein required for de novo pyrimidine biosynthesis. Pathological CAD variants cause a developmental and epileptic encephalopathy which is highly responsive to uridine supplements. CAD deficiency is difficult to diagnose because symptoms are nonspecific, there is no biomarker, and the protein has over 1000 known variants. To improve diagnosis, we assessed the pathogenicity of 20 unreported missense CAD variants using a growth complementation assay that identified 11 pathogenic variants in seven affected individuals; they would benefit from uridine treatment. We also tested nine variants previously reported as pathogenic and confirmed the damaging effect of seven. However, we reclassified two variants as likely benign based on our assay, which is consistent with their long‐term follow‐up with uridine. We found that several computational methods are unreliable predictors of pathogenic CAD variants, so we extended the functional assay results by studying the impact of pathogenic variants at the protein level. We focused on CAD's dihydroorotase (DHO) domain because it accumulates the largest density of damaging missense changes. The atomic‐resolution structures of eight DHO pathogenic variants, combined with functional and molecular dynamics analyses, provided a comprehensive structural and functional understanding of the activity, stability, and oligomerization of CAD's DHO domain. Combining our functional and protein structural analysis can help refine clinical diagnostic workflow for CAD variants in the genomics era.

1 September 2020 in Journal of Movement Disorders
Verified
Journal Article
Open access
PDF file
MMMyriam Ley Martos
Myriam Ley Martos
MRMaría Jesús Salado Reyes
María Jesús Salado Reyes
RIRosario Marín Iglesias
Rosario Marín Iglesias
CMCarmen Gutiérrez Moro
Carmen Gutiérrez Moro
MLManuel Lubián
Manuel Lubián
LPLorena Estepa Pedregosa
Lorena Estepa Pedregosa

27 September 2025 in Neurología
Verified
Journal Article
Open access
CDCristina Domínguez-González
Cristina Domínguez-González
MBMiguel-Ángel Barba-Romero
Miguel-Ángel Barba-Romero
CEC. Caballero Eraso
C. Caballero Eraso
JHJ. de Las Heras
J. de Las Heras
EME. Farrero Muñoz
E. Farrero Muñoz
JDJ. Díaz-Manera
J. Díaz-Manera